Controlled trial of hydroxychloroquine and d‐penicillamine singly and in combination in the treatment of rheumatoid arthritis

Arthritis & Rheumatism

Volumn 27, Issue 3, 1984, Pages 267-276

  Bunch, Thomas W ^a,c   O'Duffy, J Desmond ^a,c   Tompkins, Richard B ^a,c   O'Fallon, W Michael ^b,c  

^a Division of Rheumatology and Internal Medicine ^*

^b Department of Medical Statistics and Epidemiology ^*

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; PENICILLAMINE; PLACEBO;

ADVERSE DRUG REACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMPARISON; DRUG EFFICACY; DRUG THERAPY; DRUG TOLERANCE; EFFICACY; HEMATURIA; HUMAN; INTOXICATION; JOINT; MOUTH; MOUTH ULCER; MUSCLE; NERVOUS SYSTEM; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; POLYMYOSITIS; PROTEINURIA; RASH; RHEUMATOID ARTHRITIS; SKIN TOXICITY; THERAPY; THROMBOCYTOPENIA; TOXICITY;

ADULT; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMAN; HYDROXYCHLOROQUINE; MALE; MIDDLE AGE; PENICILLAMINE; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0021328911     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780270304     Document Type: Article

References (18)

1. 1958 revision of diagnostic criteria for rheumatoid arthritis
2. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
3. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities
4. Effects of certain antirheumatic drugs on normal human peripheral blood lymphocytes: inhibition of mitogen‐ and antigen‐stimulated incorporation of tritiated thymidine
5. The course of rheumatoid arthritis in patients receiving simple medical and orthopedic measures
6. The prevalence of rheumatoid arthritis: follow‐up evaluation of the effect of criteria on rates in Sudbury, Massachusetts
7. Controlled trial of D(‐)penicillamine in severe rheumatoid arthritis
8. Synthetic D(‐)penicillamine in rheumatoid arthritis: double‐blind controlled study of a high and low dosage regimen
9. Clinical evaluation of D‐penicillamirie by multicentric double‐blind comparative study in chronic rheumatoid arthritis
10. Clinical trial of penicillamine in rheumatoid arthritis
11. Hydroxychloroquine sulfate in rheumatoid arthritis: a six month, double‐blind trial
12. Hydroxychloroquine sulfate (“Plaquenil”) in treatment of rheumatoid arthritis
13. Azathioprine in early rheumatoid arthritis: comparison with gold and chloroquine
14. The toxicity pattern of D‐penicillamine therapy: a guide to its use in rheumatoid arthritis
15. Treatment of rheumatoid arthritis with penicillamine
16. Prior gold therapy does not influence the adverse effects of D‐penicillamine in rheumatoid arthritis
17. Ophthalmologic safety of long‐term hydroxychloroquine treatment